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AT BIRTH, NUTRIENT TRANSFER changes abruptly from the placental delivery, in which glucose and amino acids represent over 80% of the energy supply, to the postnatal milk diet, which provides about 50% of energy from fatty acids and lower protein (3, 21) . Metabolic adaptation of energy substrate processing with a shift in hepatic glycolysis and fatty acid oxidation occurs following birth (14) and is likely important to the maintenance of blood glucose, avoidance of excess hepatic fatty acid accumulation, and efficient utilization of amino acids for protein and peptide synthesis. Early studies showed that the activity and expression of hepatic mitochondrial and peroxisomal enzymes of fatty acid oxidation are low in the fetus and increase rapidly after birth, consistent with the onset of feeding with the high-fat milk diet (27, 44) . The n-6 and n-3 fatty acids contribute to regulation of fatty acid synthesis and oxidation in adult liver, with the n-3 fatty acids having unique effects that suppress hepatic triglyceride synthesis and secretion (22, 37, 39, 40, 50) . However, much of the recent interest in fatty acid nutrition during early development has focused on the role of the n-3 fatty acid, docosahexaenoic acid (22:6n-3) in the brain and retina (16, 18, 29) . Little attention has as yet been given to the possible role of n-3 fatty acids in the neonatal liver faced with adaptation to a high-fat milk diet although it is known that fetal and neonatal liver n-3 fatty acid accumulation depends on placental n-3 fatty acid transfer in gestation and the milk n-3 fatty acid supply after birth (1, 2, 12, 33) .
Integration of metabolic pathways is a central tenant of healthy development and organ function, with the expectation that failure to balance the supply of fatty acids with endogenous fatty acid synthesis and oxidation may lead to lipid accumulation and metabolic stress in the liver and other organs (11, 35, 42) . Metabolic control, however, is complex with the activity of enzyme pathways influenced at multiple levels, through gene expression to posttranslational protein modification, with additional developmental regulation of the expression of transcription factors (5, 31) . Recently, we described global profiling of the neonatal liver protein complement using two-dimensional polyacrylamide gel electrophoresis (2D PAGE) coupled with matrix-assisted laser desorption/ionization time of flight mass spectrometry, as well as the identification of several key proteins, including serine hydroxymethyltransferase (SHMT1) and fructose-1,6-bisphosphatase (FBP1), not previously known to be altered by n-3 fatty acids (34) . Here we extend our proteomic studies to targeted analyses of gene expression and metabolite concentrations and then integrate the results to provide a novel conceptual framework for the role of n-3 fatty acids in early metabolic regulation, not only of fatty acids, but also directing carbons toward anabolic pathways such as the pentose phosphate pathway and synthesis of nonessential amino acids.
MATERIALS AND METHODS
All procedures involving animals were approved and carried out in accordance with the Animal Care Committee of the University of British Columbia and conformed to the guidelines of the Canadian Council on Animal Care. The animals were from Charles River Laboratories and were housed in a temperature-controlled animal facility with a 12-h:12-h light/dark cycle and free access to food and water throughout. In all cases, the livers were rapidly removed, immediately flash frozen in liquid nitrogen, and stored at Ϫ70°C until analyzed.
First, studies were conducted to characterize the perinatal changes in gene expression for key enzymes of hepatic fatty acid oxidation because it is likely that differences attributable to fatty acid composition may be masked in the presence of major shifts in gene expression following birth. Studies on the developmental changes in hepatic gene expression were conducted at embryonic (E) day 20 (normal term gestation 21 days), 12-24 and 48 -72 h, and 10 and 17 days postnatal in offspring of dams fed commercial rodent chow (Harlan-Teklad).
Next, we established maternal dietary conditions to alter the neonatal liver fatty acid composition. Maternal high-fat diets can alter fetal growth and increase fetal liver triglycerides and gene expression, leading to offspring at greater risk for characteristics of the metabolic syndrome (6, 30, 54) ; however, our focus is hepatic metabolic regulation by n-3 fatty acids in the absence of confounding effects attributable to altered fetal growth or liver triglycerides. Thus, for the final studies, we fed nulliparous female rats from 2 wk before breeding with semisynthetic diets that provided a constant 4,030 kcal and 180 g protein per kg complete diet, but with, as a percentage of kcal, 20% fat and either 1% 18:2n-6 and Ͻ0.1% 18:3n-3 (n-3 deficient) or 3.9% 18:2n-6 and 1.5% 18:3n-3 (n-3 adequate) ( Table 1) . These diets had no effect on litter size, offspring weight, or liver triglycerides but did alter neonatal liver fatty acids. An intake of 1% kcal 18:2n-6 meets and exceeds the needs for n-6 fatty acids for reproduction and growth, with no signs of essential fatty acid deficiency, also supporting high tissue levels of 20:4n-6 in both rats, human infants, and other species (32, 33, 51) . Linoleic acid (18:2n-6) was increased to 3.9% energy in the diet with 1.5% energy 18:3n-3 to avoid the potential loss of hepatic 20:4n-6 when 18:3n-3 represents a similar 1-1.5% kcal to 18:2n-6 (33). All litters were reduced to a standard 10 pups each on the first day after birth.
Proteomic studies to identify novel protein targets. 2D PAGE combined with matrix-assisted laser desorption/ionization time of flight mass spectrophotometry and peptide mass fingerprinting was used to identify protein targets susceptible to regulation by n-3 fatty acids in neonatal liver. Detailed methods have been published (34) .
Gene expression. RNA was extracted using the RNeasy Mini Kit (Qiagen) with DNase 1 treatment to digest contaminating genomic DNA, and then the RNA integrity was assessed from the presence of 18S and 28S rRNA bands on agarose gels. RNA (1 g) was reverse transcribed using the High Capacity cDNA Reverse Transcription Kit. Gene expression was measured by real-time PCR using the comparative Ct method (⌬⌬Ct) of relative quantification with commercially available primers and TaqMan probes specific for the target genes, with actin as the endogenous control (Applied Biosystems). Gene expression studies were based on the results of the proteomic studies, with inclusion of gene targets known to be regulated by n-3 fatty acids in adult liver (22, 40) . The genes analyzed and PCR primers are provided in Table 2 . In each case, diluted cDNA product (5 l) was incubated with 1ϫ TaqMan Universal PCR mix and 1ϫ TaqMan primer/probe mix in a final reaction volume of 20 l. The PCR assay was conducted in a 7500 Real-Time PCR System (Applied Biosystems) at 50°C for 2 min, 95°C for 10 min, followed by 50 cycles of 95°C for 15 s and 60°C for 1 min. Data were analyzed using the 7500 System Sequence Detection software, version 1.2.3 (Applied Biosystems).
Western immunoblotting. Liver tissues were homogenized in buffer (sodium chloride, sodium deoxycholate, Triton X-100, SDS, 50 mM Tris, pH 8.0) diluted and boiled with sample loading dye (Tris, SDS, glycerol, Coomassie blue). Samples corresponding to 40 g protein were separated by SDS-PAGE, transferred to polyvinylidene fluoride membranes (Bio-Rad), and dried overnight. Membranes were incubated with antibodies specific for peroxisome proliferatoractivated receptor-␣ (PPAR-␣), sterol regulatory element-binding protein 1 (SREBP1), or carbohydrate response element-binding protein (ChREBP) (NovusBio) for 2 h at room temperature. After three washes in Tris-buffered saline containing 0.1% Tween-20, the membranes were incubated for 1 h at room temperature with secondary alkaline phosphatase-conjugated antibodies (Santa Cruz Biotechnology) and visualized using LumiPhos substrate (Thermo Scientific) with the Chemigenius detection system using GeneTools software (Syngene) for densitometric analysis.
Biochemical analysis. For lipid analysis, total liver lipids were extracted, and then the lipid classes were separated and quantified by high-performance liquid chromatography (HPLC) and fatty acids determined by gas chromatography (19) . Glucose was measured using a glucose assay kit (Sigma-Aldrich), and glycogen was quantified as the difference in glucose following incubation with amyloglucosidase, 50 g/ml in 50 mM sodium acetate with 0.02% wt/vol bovine serum albumin for 1 h. NADPH and NADP were analyzed using commercial reagents (BioVision). Protein abundance of SHMT1, which catalyzes the reversible conversion of serine to glycine, was increased in neonatal livers with high n-3 fatty acids (34) . We, therefore, quantified liver glycine and serine by HPLC coupled with fluorescence detection The diets provided 4.03 kcal/g, 20% energy from fat and identical protein, carbohydrate, vitamins, and minerals per kcal, as described in detail (19). and electrospray ionization mass spectrometry using 13 C-labeled glycine and serine (Cambridge Chemical) as internal standards, after derivatization with ortho-phthaldialdehyde and 3-mercaptopropionic acid based on Terrlink et al. (43) . Because of the altered protein abundance of catalase and galactokinase ( Fig. 2) , we also quantified glutathione by HPLC with fluorescence detection using the same method described for amino acids. Protein carbonyls were analyzed with commercial reagents (Cayman Chemical), and protein was assayed according to Lowry et al. (28) .
Statistical analysis and data interpretation. Results are presented as means Ϯ SE or SD as indicated. Differences between groups were determined using unpaired t-tests using the SPSS statistical software package for Windows (version 17; SPSS). Differences were considered significant at P Ͻ 0.05. The results of the protein, gene expression, and biochemical analyses were combined onto metabolic pathways to enable consideration of the potential changes in hepatic fatty acid, glucose, and amino acid metabolism that result when the supply of n-3 fatty acids is altered.
RESULTS

Ontogenic expression of genes.
To establish the time point at which to study changes in gene expression that result from manipulation of the maternal dietary fatty acids, changes in the expression of gene transcripts for carnitine palmitoyltransferase (Cpt1a) and acyl CoA oxidase (Acox1) were determined over the perinatal period. Cpt1a and Acox1 increased 60-and 20-fold, respectively, from E20 to 12-24 h postnatal, with a decline at 48 -72 h postnatal and a plateau to 17 days postnatal at levels about 50-and 7-fold higher for the two genes, respectively, than at E20 (Fig. 1) . Ppar-␣ increased about 1.5-fold from E20 to 48 -72 h postnatal, with no change in expression to 17 days postnatal. We, therefore, conducted studies to assess the role of n-3 fatty acids on early hepatic metabolic development at 3 days (72 h) postnatal.
Maternal dietary fatty acids and offspring liver fatty acids. Next, rat dams were fed diets designed to alter the neonatal liver fatty acids, without altering growth or hepatic triglyceride accumulation. As intended, there was no difference in litter size (15 Ϯ 1.0 and 14 Ϯ 0.67 pups/litter in the n-3-deficient and n-3-adequate groups, respectively), birth weight (6.7 Ϯ 0.42 and 6.9 Ϯ 0.17 g), and weight at 3-days of age (8.1 Ϯ 0.49 and 9.0 Ϯ 0.20 g). In addition, there was no difference in liver triglycerides (229 Ϯ 34.9 and 269 Ϯ 45.6 g/mg protein) or total phospholipid (156 Ϯ 2.67 and 173 Ϯ 6.86 g/mg protein) between the n-3-deficient and n-3-adequate pups. The maternal diets did result in significant differences in the liver fatty acids of the 3-day-old offspring. Neonates of dams fed the n-3 fatty acid adequate diet showed a marked increase in 22:6n-3 compared with offspring of the n-3 fatty acid-deficient group, from a mean of 10.7 to 24.9 g/100 g fatty acid and 5.05 to 13.0 g/100 g fatty acid in liver phosphatidylcholine and phosphatidylethanolamine of the n-3-deficient and -adequate groups (Table 3) . Levels of 18:3n-3 were low in liver phospholipids, increasing to only 0.14 g/100 g fatty acids in phosphatidylcholine and not different in phosphatidylethanolamine between the groups. Regardless of a statistically significant higher liver phospholipid 20:5n-3 in offspring in the n-3-adequate compared with -deficient group, 20:5n-3 remained less than 1 g/100 g fatty acid in all offspring. The maternal diet fatty acid composition had no significant effect on 18:2n-6 or 20:4n-6 in the offspring liver phospholipids although the long-chain n-6 fatty acids, 22:4n-6 and 22:5n-6, were higher in the n-3 fatty acid-deficient group. For the gene expression and metabolite analyses, comparisons are made between the neonatal livers with "high" compared with "low" n-3 fatty acids, reflecting offspring of dams fed the n-3-adequate and -deficient diets, respectively, recognizing that differences in the long-chain n-6 fatty acids, 22:4n-6 and 22:5n-6, were also present.
Proteomic studies to identify novel protein targets. 2D gel proteomics was used to identify proteins that differed between neonatal livers with low compared with high n-3 fatty acids. Although the results have been published (34), they are referred to here because they guided the targeted studies of gene expression and metabolites beyond pathways known to be influenced by n-3 fatty acids in adult liver (22) . Proteins shown to differ between the groups included FBP1, glycerol-3-phosphate dehydrogenase (GPD1), galactokinase 1 (GALK1), SHMT1, 40S ribosomal protein SA, elongation factor 1-␥, protein disulfide-isomerase A6, catalase, cytokeratin-8, and 60-kDa heat shock protein, which were all higher, and argininosuccinate synthase (ASS1), which was lower, in livers with high compared with low n-3 fatty acids (34) .
Gene expression in neonatal livers. To determine whether the proteins shown to differ in abundance in livers with high or low n-3 fatty acids are regulated at the level of gene transcription, we next used real-time PCR to assess gene expression for a subset of the targets identified above. Consistent with the higher protein abundance for SHMT1 and GPD1, livers of 3-day-old offspring with higher n-3 fatty acids had significantly higher mRNA for Shmt1 and Gpd1 and a trend to higher Fbp1 although this was not statistically significant (P ϭ 0.15, Fig. 2) . In contrast to the higher GALK1 and lower ASS1 in livers with higher n-3 fatty acids, gene expression for Galk1 and Ass1 did not differ between the diet groups.
Although none of the proteins described above have previously been identified as targets of n-3 fatty acids, the n-3 fatty acids are known to regulate the expression of genes for enzymes of fatty acid and glucose metabolism in adult liver (22) . Therefore, we next assessed gene expression for key enzymes of fatty acid metabolism, including Cpt1a and Acox1, which encode enzymes of mitochondrial and peroxisomal fatty acid oxidation, respectively, and fatty acid synthase (Fasn), acetyl CoA carboxylase-␣ (Acaca), and stearoyl CoA (⌬9) desaturase 1 (Scd1), which encode enzymes involved in fatty acid synthesis, the ⌬9 desaturation of fatty acids, and ATP citrate lyase (Acly), which encodes the enzyme that cleaves cytosolic citrate to oxaloacetate and acetyl CoA. We also assessed fatty acid desaturase 2 (Fads2) and elongase 5 (Elov5), which encode enzymes needed for desaturation and elongation of n-3 and n-6 fatty acids to their long-chain metabolites, as well as 3-hydroxy-3-methylglutaryl-CoA reductase (Hmgcr), which encodes the cytosolic HMG CoA reductase involved in cholesterol synthesis. Livers of 3-day-old offspring with high n-3 fatty acids showed significantly higher gene expression of Cpt1a, Acox1, and Elov5, and lower Acly and Scd1 (Fig. 3) . Transcript abundance for Fasn, Acaca, and Hmgcr, however, were not different between the groups (Fig. 3) .
The higher Cpt1a and Acox1 suggest higher fatty acid oxidation. Fatty acid oxidation generates acetyl CoA, which requires oxaloacetate for condensation to form citrate. We, therefore, assessed gene expression of pyruvate carboxylase (Pcx), which encodes the enzyme that carboxylates pyruvate to oxaloacetate, as well as serine dehydratase (Sds), which dehydrates and deaminates serine to form pyruvate. However, we found no significant differences in expression of these genes in neonatal livers with high or low n-3 fatty acids (Fig. 4) . Consistent with the increased Cpt1a and Acox1, neonatal livers with high n-3 fatty acids did have lower liver-type pyruvate kinase (Pklr), although phosphofructokinase (Pfkl) and glucose-6-phosphate dehydrogenase (G6pdx), genes for regulatory enzymes upstream in the glycolytic pathway, were not altered. Fig. 2 . Gene expression of proteins shown to differ in abundance in liver of 3-day-old offspring of rats fed diets differing in fatty acid composition during gestation (34) . Values are means Ϯ SE, n ϭ 6/group. *Different from n-3 fatty acid-deficient, P Ͻ 0.05. def: deficient, adeq: adequate. Shmt1, serine hydroxymethyltransferase; Gpd1, glycerol-3-phosphate dehydrogenase; Fbp1, fructose-1,6-bisphosphatase; Galk1, galactokinase 1; Ass1, argininosuccinate synthase.
Transcriptional regulation. In adult liver, polyunsaturated fatty acids upregulate gene expression through activation of the nuclear receptor PPAR-␣ and downregulate gene expression, particularly for genes of fatty acid synthesis and glycolysis through inhibition of the transcription factors SREBP1 and ChREBP (22) . Therefore, we next assessed whether differences in gene and protein expression were accompanied by differences in abundance of these transcription factors. We found no difference in gene expression but higher protein expression of PPAR-␣ and lower protein abundance of the precursor (inactive) SREBP1 protein in neonatal livers with higher n-3 fatty acid (Fig. 5 ). We were unable to detect the mature (nuclear) form of SREBP1 in 3-day-old livers. ChREBP gene and protein expression were not different between the groups.
Biochemical measures. Quantification of liver glycine and serine by HPLC-mass spectrometry showed significantly lower glycine but no difference in serine in livers with high n-3 fatty acids (Table 4) . Liver glucose and glycogen levels were not different between the groups. NADPH and the NADPH/NADP ratio were higher in neonatal liver with high n-3 fatty acids (Table 3) . Despite the absence of a difference in Hmgcr, liver unesterified and esterified cholesterol were higher in livers with high n-3 fatty acids; however, HMG CoA reductase is also regulated by posttranslational mechanisms including enzyme degradation and reversible phosphorylation (15) . Consistent with their higher catalase abundance (34), we found higher glutathione in liver with high n-3 fatty acids although protein carbonyls were not different between the groups (Table 4) .
Pathway integration. Figure 6 combines results of the analyses of gene expression, metabolites, and protein abundance on a schematic of key pathways of fatty acid, glucose, and amino acid metabolism. When integrated, these results provide novel evidence that higher n-3 fatty acids, not only alter fatty acid oxidation and the use of glucose as a source of energy, but also intersect anabolic pathways relating to amino acid metabolism. Beginning with fatty acid metabolism, neonatal livers with high n-3 fatty acids had higher Cpt1a and Acox1 and higher GPD1, consistent with increased triglyceride catabolism and fatty acid oxidation. Acetyl CoA from fatty acid oxidation can enter the citric acid cycle for oxidation to CO 2 or be used for synthesis of ketones via mitochondrial HMG CoA synthase 2 (Hmgcs2), or, after export from the mitochondria as citrate and cleavage to oxaloacetate and Acly, it can be used for cholesterol or fatty acid synthesis. Unexpectedly, even though Cpt1a and Acox1 were higher, Acly was lower in liver with high n-3 fatty acids, with no evidence of altered Hmgcs2. Overall, the pattern is consistent with increased fatty acid oxidation without a net increase in generation of acetyl CoA, suggesting decreased generation of acetyl CoA from other sources. Consistent with this, lower Pklr suggests decreased entry of glucose carbons to the citric acid cycle at the level of phosphoenolpyruvate conversion to pyruvate, hence giving no net change in energy metabolism via the citric acid cycle. The results from the proteomic studies to show higher FBP1, GPD1, and GALK1 suggest increased gluconeogenesis. Although consistent with increased triglyceride-glycerol metabolism, this also raises the question of the metabolic fate of glucose carbons when not used for energy. Pflk also catalyzes a rate-limiting step in hepatic glycolysis and is known to be regulated at the Fig. 4 . Gene expression for enzymes of ketone synthesis, glucose, and amino acid metabolism in liver from 3-dayold offspring of rats fed diets differing in fatty acid composition during gestation. Values are means Ϯ SE. *Different from n-3 fatty acid-deficient, P Ͻ 0.05. Hmgcs2, 3-hydroxy-3-methylglutaryl-CoA synthase 2; Pcx, pyruvate carboxylase; Sds, serine dehydratase; Pklr, liver-type pyruvate kinase; Pfkl, phosphofructokinase; G6pdx, glucose-6-phosphate dehydrogenase. level of gene transcription (26, 38, 48 ), but we found no evidence of a difference in Pfkl. As shown in Fig. 6 , the lower Pklr, with no difference in Pfkl, points to a redirection of glucose carbons away from the citric acid cycle toward the pentose phosphate pathway and synthesis of serine and glycine, which is consistent with the increase in SHMT1 protein and gene abundance and NADPH. Notably, both the pentose phosphate pathway and endogenous synthesis of serine and glycine require a source of nitrogen. In this regard, the results from the proteomic studies showing lower ASS1 protein abundance and increased abundance of proteins involved in protein translation are intriguing and consistent with increased use of amino acid nitrogen in biosynthetic pathways in which glucose provides the carbon background.
DISCUSSION
In this report, we describe a novel approach to extend understanding of the role of n-3 fatty acids in metabolic integration and regulation in neonatal liver. We previously used 2D gel proteomics to identify proteins robustly altered in response to changes in the maternal diet n-3 fatty acids, demonstrating differences in the abundance of proteins in multiple metabolic pathways (34) . Here, we further develop the model to targeted studies of gene expression and metabolites and then integrate the results to provide an overview of the metabolic implications of the neonatal n-3 fatty acid supply. The results show that, in the absence of differences in growth, simply altering the long-chain n-3 fatty acids in the neonatal liver leads to changes in the abundance of proteins and expres- Values are means Ϯ SE for n ϭ 4 litters/diet group for the amino acids and glutathione, n ϭ 8/group for NADPH and n ϭ 6/group for all other assays. *Significantly different from n-3 fatty acid-deficient group, P Ͻ 0.05. Fig. 6 . Tentative integrated schematic showing sites of altered gene and protein expression and metabolite differences in livers of 3-day-old neonates. Upward and downward arrows indicate higher or lower levels in liver with high compared with low n-3 fatty acid, as in Table 3 . Underlined genes and metabolites were measured but not different between the diet groups. Macronutrients are denoted by hexagons to indicate that the balance is determined by hepatic uptake, synthesis, oxidation and secretion. EEF1G, elongation factor 1-␥; PDIA6, protein disulfide-isomerase A6. *Peroxisomal enzyme. sion of genes for enzymes regulating fatty acid oxidation, glycolysis, gluconeogenesis, and amino acid metabolism, with changes in the concentrations of NADPH, glycine, and glutathione. We suggest that these results are best explained by a role of n-3 fatty acids in facilitating metabolic adaptation to feeding with a high-fat milk diet, with higher fatty acid oxidation, and sparing of glucose and amino acids for anabolic pathways of protein and peptide synthesis (Fig. 6) .
Regardless of the considerable interest in the role of n-3 fatty acids in the developing brain (16, 18, 29) , very little is yet known about the role of these fatty acids in the liver. The transition from placental nutrient transfer to the milk diet at birth involves an abrupt change in the energy substrate supply for which coordinated changes in hepatic metabolism must occur to enable fatty acid oxidation, prevent excess lipid accumulation, maintain glucose homeostasis, and support peptides, protein, and other biosynthetic processes. In addition, whereas muscle is the major site of fatty acid oxidation in adults, muscle mass and physical activity are low in the neonate, and thus the liver may play a more central role in fatty acid metabolism than later in life. Notably, excessive hepatic lipid accumulation is problematic in parenterally fed neonates given intravenous soybean oil emulsions, and this is alleviated by the use of fish oils rich in 20:5n-3 and 22:6n-3 (10) although the mechanisms are not well understood. In the present study, higher Cpt1a, Acox1, and GPD1, with lower Acly and Scd1, is consistent with increased triglyceride catabolism and lower fatty acid synthesis in liver with high n-3 fatty acids (Fig. 6) . The higher expression of enzymes of fatty acid oxidation was accompanied by lower Pklr, suggesting a reciprocal decrease in glucose oxidation as fatty acid oxidation increased. These findings highlight a key role for n-3 fatty acids in early regulation of fatty acid and glucose metabolism.
Studies on the effects of dietary n-3 fatty acids on fatty acid and glucose metabolism often overlook the essential roles of glucose-derived carbons beyond their role as an energy source. Our finding of lower Pklr, but higher Shmt1 and NADPH, in neonatal livers with high n-3 fatty acids points to redirection of glucose carbons toward the pentose phosphate pathway and to the carbon backbone for synthesis of the nonessential amino acids, serine and glycine. To the best of our knowledge, ours are the first studies to show higher protein abundance of SHMT1 attributable to higher liver n-3 fatty acids, confirmed at the mRNA level by targeted real-time PCR in the present study. The perhaps unexpected lower hepatic free glycine with high n-3 fatty acids could reflect increased use of glycine for protein, purine, or glutathione synthesis. Although the higher NADPH, lower glycine, and decreased Pklr gene expression with high n-3 fatty acids are consistent with increased entry of glucose carbons to the pentose phosphate pathway (Fig. 6) , we note that specific data to show this are not provided by our studies.
A role of n-3 fatty acids in regulation of amino acid and protein metabolism is intriguing. In addition to increased SHMT1, our proteomic studies showed higher elongation factor-1␥ and protein disulfide isomerase, and lower ASS1, which together suggest decreased amino acid catabolism and increased protein synthesis. Recent studies using stable isotopes in developing and adult animals have reported that feeding 20:5n-3 and 22:6n-3 led to lower oxidation of 13C-labeled phenylalanine and increased incorporation into muscle proteins (4, 13) . Similarly, supplementation with 20:5n-3 and 22:6n-3 increased insulin-stimulated incorporation of phenylalanine into muscle proteins in elderly subjects (41) . Clearly, the possibility that n-3 fatty acids influence amino acid metabolism, perhaps directly through regulation of gene and protein expression (Fig. 6 ), or via insulin or other pathways (4, 13, 41) and the implications for lean tissue accretion requires further investigation.
Whereas the effects of n-3 and n-6 fatty acids in regulation of fatty acid and glucose metabolism in the adult liver have been described (7-9, 17, 22-25, 36, 40, 45, 46, 49, 52, 53) , several transcription regulators, including SREBP and PPAR, show distinct developmental changes (5, 31) , and this, together with the high-fat milk diet, sets the stage to consider that n-3 fatty acids may have different effects in the infant compared with adult liver. In the present study, higher neonatal liver n-3 fatty acids were associated with higher Acox1 and Cpt1a and lower Pklr and Scd1, which is consistent with the effect of n-3 fatty acids in the adult liver (9, 17, 23-25, 36, 45, 52, 53) . However, in contrast to the adult liver, we found no evidence that n-3 fatty acids decreased Fasn or Acaca in the neonatal liver, which may mean that fatty acid synthesis is maximally inhibited in the infant animal fed a milk diet with about 50% energy from fat. Studies in adult rats have reported lower hepatic Elov5 mRNA following feeding with fish oil, which is rich in 20:5n-3 and 22:6n-3 (47) . Because the expression of Elov5 is low in the fetal rat liver and increases after birth (47), the higher Elov5 in 3-day-old rat liver with higher n-3 fatty acids may indicate that the n-3 fatty acids promote a more "metabolically mature" liver, also consistent with facilitation of adaptation to the extrauterine nutrient supply. Our results for Elov5, Fasn, and Acaca expression also highlight that the effects of n-3 fatty acids in the developing liver may differ from those in the adult liver. We also note that the altered abundance of GALK1, FBP1, and ASS1 protein (34) was not accompanied by differences in mRNA, suggesting that these enzymes are not regulated by n-3 fatty acids at the level gene expression. Whether or not these hepatic proteins are also regulated by n-3 fatty acids in adult and the mechanism though which n-3 fatty acids influence the abundance of these proteins should be considered in future studies.
The regulation of gene expression by n-3 fatty acids in adult liver is thought to occur via interaction with transcription factors, including PPAR-␣, SREBP1, and ChREBP (22, 40) . We found higher protein abundance for PPAR-␣ and lower SREBP1 in neonatal livers with high compared with low n-3 fatty acids (Fig. 5 ) consistent with studies in adult liver (22, 40) although no difference in ChREBP was found. PPAR-␣ enhances transcription of genes for fatty acid oxidation and inhibits pyruvate kinase, whereas SREBP enhances transcription of genes for lipogenesis (22, 52, 53) . These findings raise the possibility that the higher PPAR-␣ and lower SREBP1 associated with high neonatal liver n-3 fatty acids may be involved in the higher Cpt1a, Acox1, and Elov5 and lower Scd1, Acyl, and Pklr gene expression. Additional studies, however, would need to address whether DNA binding activity of any of these transcription factors does indeed differ when the n-3 fatty acid content of the developing liver is altered.
In summary, the present study demonstrates that the maternal dietary fatty acids, particularly the n-3 fatty acids, are relevant to metabolic development in offspring liver. Our global approach integrating protein, gene, and metabolite measures across multiple pathways offers novel insights into pathways altered by the n-3 fatty acids, extending the focus beyond energy metabolism to biosynthetic pathways. We have emphasized that the neonatal liver is faced with a high-fat milk diet and that the metabolic importance of liver and muscle may differ from the adult as a result of the low muscle mass and physical activity of the newborn. The roles of n-3 fatty acids in directing glucose to biosynthetic pathways and the implications for lean tissue accretion merit further study.
